CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Supernus Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 24, 2025
Patent NumberGrant DateTitleTotal Oppositions
Dec 20, 2017Formulations Of Mazindol1
Aug 9, 2017Use Of A Mixture Of Two Or More Enteric Materials To Regulate Drug Release Via Membrane Or Matrix For Systemic Therapeutics1

Top competitors of Supernus Pharmaceuticals

List of top competitors of Supernus Pharmaceuticals based on patent oppositions.